ASNC is the premier source for education and quality in the rapidly expanding area of cardiac amyloidosis. Through its initiatives and partnerships, ASNC is supporting a collaborative approach to awareness, early diagnosis and effective treatments that will save lives and improve quality of life for patients with CA.
ASNC is uniquely qualified to provide education, information and advocacy that ensures appropriate referrals for Tc-99m PYP imaging; supports high-quality testing, interpretation and reporting of Tc-99m PYP imaging by imagers; and encourages fair reimbursement of Tc-99m PYP services and approval of CA treatment agents.
Access the latest educational resources and activities incuding our new app and share with your colleagues!
Join us March 11-13 for a unique virtual meeting focused on optimizing nuclear cardiology labs along the spectrum of size, location, and budget.
Watch our expert faculty do an intensive on "Cardiac Amyloidosis: Best Practices to Optimize Patient Care and Your Practice".
View more information.
NEW for members!Find below our new 11"x17" Cardiac Amyloidosis Flowchart and our Transthyretin Cardiac Amyloidosis: Frequently Asked Questions PDF. Not a member? Join ASNC today!
Download our brand-new 11"x17" flowchart designed to guide your clinical assessment of cardiac amyloidosis.
Download our Transthyretin Cardiac Amyloidosis: Frequently Asked Questions PDF.
Download the Clinical and Quality Resources App
Hover over the QR code with your camera to download